Erythema nodosum and antitubercular therapy

Area of Science:

• Dermatology
• Infectious Diseases
• Internal Medicine

Background:

• Erythema nodosum is an inflammatory condition often associated with infections or systemic diseases.
• A highly positive Mantoux test suggests a possible link to tuberculosis, even without other clinical signs.
• Idiopathic erythema nodosum requires effective management strategies.

Purpose of the Study:

• To evaluate the efficacy of antitubercular therapy for erythema nodosum patients with a strongly positive Mantoux test.
• To determine if treatment is beneficial even when active tuberculosis is not definitively diagnosed.

Main Methods:

• Retrospective analysis of 52 patients diagnosed with idiopathic erythema nodosum and a positive Mantoux reaction (average 19 mm) between 1988 and 2001.
• Treatment with antitubercular therapy was administered in the absence of other evidence of active tuberculosis.
• Data from 47 patients were analyzed.

Main Results:

• Antitubercular therapy led to the cessation of new lesions in 45 out of 47 patients within 6-8 weeks.
• The remaining two patients experienced subsidence of existing lesions with treatment.
• The therapy was well-tolerated, with only minor adverse events reported in two patients.

Conclusions:

• Antitubercular therapy is a valuable management option for erythema nodosum, particularly in endemic areas.
• Treatment efficacy was observed even without a detectable focus of tuberculosis.
• This approach offers a potential solution for managing erythema nodosum linked to latent or subclinical tuberculosis.